Capital Analysts LLC Buys 1,628 Shares of The Allstate Corporation $ALL

Key Points

• Capital Analysts LLC significantly increased its stake in The Allstate Corporation by acquiring an additional 1,628 shares, bringing its total holdings to 2,068 shares valued at approximately $428,000.
• Allstate recently reported earnings of $5.94 per share for the last quarter, greatly exceeding the consensus estimate of $3.20, alongside a year-over-year revenue increase of 5.8%.
• The company declared a quarterly dividend of $1.00 per share, translating to an annualized dividend yield of 1.9%, with a payout ratio of 18.81%.

Capital Analysts LLC lifted its stake in The Allstate Corporation (NYSE:ALL - Free Report) by 370.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,068 shares of the insurance provider's stock after acquiring an additional 1,628 shares during the quarter. Capital Analysts LLC's holdings in Allstate were worth $428,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Erste Asset Management GmbH grew its stake in shares of Allstate by 9.1% in the first quarter. Erste Asset Management GmbH now owns 63,647 shares of the insurance provider's stock worth $13,142,000 after acquiring an additional 5,308 shares during the period. Humankind Investments LLC grew its stake in shares of Allstate by 6.8% in the first quarter. Humankind Investments LLC now owns 1,766 shares of the insurance provider's stock worth $366,000 after acquiring an additional 112 shares during the period. Venture Visionary Partners LLC grew its stake in shares of Allstate by 58.1% in the first quarter. Venture Visionary Partners LLC now owns 2,509 shares of the insurance provider's stock worth $520,000 after acquiring an additional 922 shares during the period. Credit Agricole S A grew its stake in shares of Allstate by 64.1% in the first quarter. Credit Agricole S A now owns 320,292 shares of the insurance provider's stock worth $66,323,000 after acquiring an additional 125,148 shares during the period. Finally, Banco Bilbao Vizcaya Argentaria S.A. grew its stake in shares of Allstate by 2.8% in the first quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 45,031 shares of the insurance provider's stock worth $9,325,000 after acquiring an additional 1,228 shares during the period. 76.47% of the stock is currently owned by institutional investors.

Allstate Price Performance

Shares of NYSE:ALL opened at $205.1590 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $214.76. The company has a market capitalization of $54.06 billion, a P/E ratio of 9.65, a P/E/G ratio of 0.84 and a beta of 0.35. The firm's 50 day simple moving average is $199.16 and its two-hundred day simple moving average is $199.01.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, beating the consensus estimate of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $15.05 billion for the quarter, compared to the consensus estimate of $16.59 billion. During the same quarter in the previous year, the firm earned $1.61 earnings per share. The company's revenue for the quarter was up 5.8% on a year-over-year basis. Research analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a dividend of $1.00 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $4.00 annualized dividend and a yield of 1.9%. Allstate's payout ratio is currently 18.81%.

Wall Street Analyst Weigh In

ALL has been the topic of a number of research reports. Morgan Stanley raised their price objective on shares of Allstate from $235.00 to $245.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. BMO Capital Markets raised their price objective on shares of Allstate from $230.00 to $235.00 and gave the stock an "outperform" rating in a report on Wednesday. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a report on Tuesday, August 5th. Keefe, Bruyette & Woods raised their price objective on shares of Allstate from $237.00 to $246.00 and gave the stock an "outperform" rating in a report on Wednesday, August 6th. Finally, Jefferies Financial Group raised their price objective on shares of Allstate from $254.00 to $255.00 and gave the stock a "buy" rating in a report on Monday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $230.73.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.